Pluro Fertility, an Indian startup, just scored ₹125 Cr (about $15 Mn) in a Series A funding round led by Bessemer Venture Partners. This is a big deal for both health tech and the growing startup scene in India. It’s kind of like what’s happening with direct-to-consumer (D2C) companies, where digital brands are changing how things are done.
This Series A round values Pluro Fertility at ₹1,000 Cr (around $112 Mn), which puts them in the same category as other venture capital-backed startups in India, mirroring the growth seen with the fastest-growing D2C brands. Other investors also jumped in, from healthcare and tech; they are from companies like MediAssist and PharmEasy. This shows that people are getting more confident in healthcare models that use technology and focus on the consumer.
Jaydeep Tank, Parikshit Tank, and Bhaskar Shah started Pluro Fertility in 2025. They run tech-powered fertility clinics with IVF specialists. They take care of all the behind-the-scenes stuff like managing the business, following the rules, marketing, and using digital tools. They got the idea from the direct-to-consumer world by getting rid of inefficiencies, making things easier to do, and improving the customer experience.
With this new funding, Pluro wants to grow fast. They want to have 25 locations up and running by March 2026 and over 100 clinics in three years, similar to the growth plans you see from direct-to-consumer companies. Pluro is all about technology, strong foundations, and quality treatment, which is like what’s happening with D2C businesses where the backend operations create a good customer experience.
According to Jaydeep Tank, Pluro helps fertility specialists who have problems with resources and infrastructure. Pluro gives them the tools to provide reproductive care with research, digital tools, and a smooth patient experience.
This funding comes at a good time since the fertility market in India is booming because of things like lifestyle changes and people having kids later in life. The IVF market is expected to be worth over $5 Bn by 2033.
Other investments in health tech, show that tech is making healthcare more accessible, similar to how direct-to-consumer brands changed retail and wellness.
This all means that companies that put the consumer first, whether they’re direct-to-consumer brands or healthcare companies, are succeeding by using technology and focusing on trust and experience. Pluro Fertility is just one more example of a digitally-driven success story in India’s growing innovation economy.
